SUBSCRIBE
SUBSCRIBE
News   Drug Development

Study Finds Pfizer Inc.'s Zoloft, Forest Laboratories, Inc.'s Lexapro the Best of Newer Antidepressants

January 29, 2009 | 
1 min read

THURSDAY, Jan. 29 (HealthDay News) -- Sertraline (Zoloft) and escitalopram (Lexapro) are the best of 12 new-generation antidepressants, while reboxetine is the least effective, a new analysis shows.

Clinical research Postmarket research
Pfizer
MORE ON THIS TOPIC
Two boxing gloves give a fist bump on a colored background. Collage art
Lung cancer
Summit’s Bispecific Beats Yet Another Cancer Med, Pressuring Keytruda’s ‘Supremacy’
April 23, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Bristol Myers Squibb office in California
Neuropsychiatric disorders
‘Strike 2?’ BMS Stumbles Again as Cobenfy Disappoints in Schizophrenia
April 23, 2025
 · 
2 min read
 · 
Tristan Manalac
Gilead's headquarters in Silicon Valley
Breast cancer
Gilead’s Trodelvy, With Keytruda, Slows Disease Progression in Triple-Negative Breast Cancer
April 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Breast Cancer awareness month card illustration. Pink ribbon and hand fist up power in retro collage craft style. Design concept for disease prevention or october support campaign.
Breast cancer
AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data
April 22, 2025
 · 
2 min read
 · 
Tristan Manalac